A new study found that solriamfetol, a medication approved by the US Food and Drug Administration (FDA) for several sleep conditions like narcolepsy and sleep apnea, has properties that can treat ADHD symptoms. Craig Surman, MD, director of the clinical and research program in adult ADHD at Massachusetts General Hospital and associate professor at Harvard medical school, led the study. He also serves as co-chair of the professional advisory board of the nonprofit, CHADD, a resource aimed to educate people about the best practices to live with ADHD and how to get diagnosed and treated.